 Heparin, Low-Molecular-Weight
"Heparin, Low-Molecular-Weight" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.
| Descriptor ID |
D006495
|
| MeSH Number(s) |
D09.698.373.400.300
|
| Concept/Terms |
Heparin, Low-Molecular-Weight- Heparin, Low-Molecular-Weight
- Heparin, Low Molecular Weight
- LMWH
- Low Molecular Weight Heparin
- Low-Molecular-Weight Heparin
|
Below are MeSH descriptors whose meaning is more general than "Heparin, Low-Molecular-Weight".
Below are MeSH descriptors whose meaning is more specific than "Heparin, Low-Molecular-Weight".
This graph shows the total number of publications written about "Heparin, Low-Molecular-Weight" by people in this website by year, and whether "Heparin, Low-Molecular-Weight" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 | | 1999 | 0 | 1 | 1 | | 2003 | 1 | 1 | 2 | | 2005 | 2 | 1 | 3 | | 2008 | 2 | 6 | 8 | | 2009 | 1 | 1 | 2 | | 2011 | 0 | 1 | 1 | | 2015 | 2 | 0 | 2 | | 2018 | 1 | 1 | 2 | | 2019 | 1 | 0 | 1 | | 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Heparin, Low-Molecular-Weight" by people in Profiles.
-
Cohen AJ, Boggio L, Billett HH, DeSancho MT, Gaddh M, Kouides P, Lim M, Nyak L, Rajan S, Rosovsky R, Streiff M, Wang TF, Baumann Kreuziger L. North American Physician Practice Patterns in the Management of Anticoagulation in Pregnancy. J Womens Health (Larchmt). 2021 06; 30(6):829-836.
-
Yang M, Li J, Sun R, Wang Y, Xu H, Yang B, Wu X, Yu L. Comparison between direct factor Xa inhibitors and low-molecular-weight heparin for efficacy and safety in the treatment of cancer-associated venous thromboembolism: A meta-analysis. J Cancer Res Ther. 2019; 15(7):1541-1546.
-
Livesay SL. Alteplase Administration Recommendations for Inpatients on Low-Molecular-Weight Heparin. J Neurosci Nurs. 2018 Feb; 50(1):2-3.
-
Mikrut K, Patel H, Kalra DK. 75-Year-Old Woman With Multiple Systemic Emboli. JAMA Cardiol. 2018 01 01; 3(1):84-85.
-
Jarrett JB, Schaffer T, Rowland K. PURLs: Should you bypass anticoagulant "bridging" before and after surgery? J Fam Pract. 2015 Dec; 64(12):794-800.
-
Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, Garcia DA, Jacobson A, Jaffer AK, Kong DF, Schulman S, Turpie AG, Hasselblad V, Ortel TL. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med. 2015 Aug 27; 373(9):823-33.
-
Wu TC, Kasam M, Harun N, Hallevi H, Bektas H, Acosta I, Misra V, Barreto AD, Gonzales NR, Lopez GA, Grotta JC, Savitz SI. Pharmacological deep vein thrombosis prophylaxis does not lead to hematoma expansion in intracerebral hemorrhage with intraventricular extension. Stroke. 2011 Mar; 42(3):705-9.
-
Jaffer AK. Perioperative management of warfarin and antiplatelet therapy. Cleve Clin J Med. 2009 Nov; 76 Suppl 4:S37-44.
-
Grant PJ, Brotman DJ, Jaffer AK. Perioperative anticoagulant management. Med Clin North Am. 2009 Sep; 93(5):1105-21.
-
Lenchus JD, Jaffer AK. Prevention of venous thromboembolism in hospitalized medical patients. Mt Sinai J Med. 2008 Oct; 75(5):449-53.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|